NGX267 Completed Phase 2 Trials for Dry Mouth / Sjogren's Syndrome (SS) Treatment

Indications	Status	Purpose	Phase
DBCOND0038951 (Dry Mouth) DBCOND0146040 (Sjogren's Syndrome (SS))	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT00637793	Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome	NGX267 (DB05152)